- Home
- MRVI vs PAMT Comparison
MRVI vs PAMT Comparison
Compare MRVI & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- PAMT
- Stock Information
- Founded
- MRVI 2014
- PAMT 1980
- Country
- MRVI United States
- PAMT United States
- Employees
- MRVI N/A
- PAMT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- PAMT Trucking Freight/Courier Services
- Sector
- MRVI Health Care
- PAMT Industrials
- Exchange
- MRVI Nasdaq
- PAMT Nasdaq
- Market Cap
- MRVI 262.9M
- PAMT 301.4M
- IPO Year
- MRVI 2020
- PAMT 1985
- Fundamental
- Price
- MRVI $1.98
- PAMT $16.37
- Analyst Decision
- MRVI Hold
- PAMT Hold
- Analyst Count
- MRVI 9
- PAMT 1
- Target Price
- MRVI $6.54
- PAMT $12.50
- AVG Volume (30 Days)
- MRVI 1.6M
- PAMT 42.1K
- Earning Date
- MRVI 05-12-2025
- PAMT 04-23-2025
- Dividend Yield
- MRVI N/A
- PAMT N/A
- EPS Growth
- MRVI N/A
- PAMT N/A
- EPS
- MRVI N/A
- PAMT N/A
- Revenue
- MRVI $259,185,000.00
- PAMT $687,396,000.00
- Revenue This Year
- MRVI N/A
- PAMT $0.61
- Revenue Next Year
- MRVI $14.23
- PAMT $10.29
- P/E Ratio
- MRVI N/A
- PAMT N/A
- Revenue Growth
- MRVI N/A
- PAMT N/A
- 52 Week Low
- MRVI $1.67
- PAMT $11.01
- 52 Week High
- MRVI $11.56
- PAMT $23.70
- Technical
- Relative Strength Index (RSI)
- MRVI 43.17
- PAMT N/A
- Support Level
- MRVI $1.96
- PAMT N/A
- Resistance Level
- MRVI $2.16
- PAMT N/A
- Average True Range (ATR)
- MRVI 0.13
- PAMT 0.00
- MACD
- MRVI 0.04
- PAMT 0.00
- Stochastic Oscillator
- MRVI 47.67
- PAMT 0.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.